Protein Phosphatase 2A Stabilizes Human Securin, Whose Phosphorylated Forms Are Degraded via the SCF Ubiquitin Ligase

REFERENCES

• Agarwal, R., and O. Cohen-Fix. 2002. Phosphorylation of the mitotic regulator Pds1/securin by Cdc28 is required for efficient nuclear localization of Esp1/separase. Genes Dev. 16:1371–1382.
   PubMed Web of Science ®Google Scholar
• Bernal, J. A., R. Luna, A. Espina, I. Lazaro, F. Ramos-Morales, F. Romero, C. Arias, A. Silva, M. Tortolero, and J. A. Pintor-Toro. 2002. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 32:306–311.
   PubMedGoogle Scholar
• Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56–61.
   PubMed Web of Science ®Google Scholar
• Breeden, L., and K. Nasmyth. 1985. Regulation of the yeast HO gene. Quant. Biol. 50:643–650.
   PubMedGoogle Scholar
• Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553.
   PubMed Web of Science ®Google Scholar
• Busino, L., M. Chiesa, G. F. Draetta, and M. Donzelli. 2004. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 23:2050–2056.
   PubMed Web of Science ®Google Scholar
• Busino, L., M. Donzelli, M. Chiesa, D. Guardavaccaro, D. Ganoth, N. V. Dorrello, A. Hershko, M. Pagano, and G. F. Draetta. 2003. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426:87–91.
   PubMed Web of Science ®Google Scholar
• Cenciarelli, C., D. S. Chiaur, D. Guardavaccaro, W. Parks, M. Vidal, and M. Pagano. 1999. Identification of a family of human F-box proteins. Curr. Biol. 9:1177–1179.
   PubMed Web of Science ®Google Scholar
• Chien, C. T., P. L. Bartel, R. Sternglanz, and S. Field. 1991. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. USA 88:9578–9582.
   PubMed Web of Science ®Google Scholar
• Ciosk, R., W. Zachariae, C. Michaelis, A. Shevchenko, M. Mann, and K. Nasmyth. 1998. An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast. Cell 93:1067–1076.
   PubMed Web of Science ®Google Scholar
• Cohen, P., C. F. Holmes, and Y. Tsukitani. 1990. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 15:98–102.
   PubMed Web of Science ®Google Scholar
• Cohen-Fix, O., J. M. Peters, M. W. Kirschner, and D. Koshland. 1996. Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev. 10:3081–3093.
   PubMed Web of Science ®Google Scholar
• Dominguez, A., F. Ramos-Morales, F. Romero, R. M. Rios, F. Dreyfus, M. Tortolero, and J. A. Pintor-Toro. 1998. hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17:2187–2193.
   PubMedGoogle Scholar
• Donzelli, M., M. Squatrito, D. Ganoth, A. Hershko, M. Pagano, and G. F. Draetta. 2002. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 21:4875–4884.
   PubMed Web of Science ®Google Scholar
• Ellis, L., E. Clauser, D. O. Morgan, M. Edery, R. A. Roth, and W. J. Rutter. 1986. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45:721–732.
   PubMed Web of Science ®Google Scholar
• Funabiki, H., K. Kumada, and M. Yanagida. 1996. Fission yeast Cut1 and Cut2 are essential for sister chromatid separation, concentrate along the metaphase spindle and form large complexes. EMBO J. 15:6617–6628.
   PubMedGoogle Scholar
• Funabiki, H., H. Yamano, K. Kumada, K. Nagao, T. Hunt, and M. Yanagida. 1996. Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature 381:438–441.
   PubMed Web of Science ®Google Scholar
• Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349:132–138.
   PubMed Web of Science ®Google Scholar
• Goldberg, Y. 1999. Protein phosphatase 2A: who shall regulate the regulator? Biochem. Pharmacol. 57:321–328.
   PubMedGoogle Scholar
• Gorr, I. H., D. Boos, and O. Stemmann. 2005. Mutual inhibition of separase and Cdk1 by two-step complex formation. Mol. Cell 19:135–141.
   PubMed Web of Science ®Google Scholar
• Gregory, M. A., and S. R. Hann. 2000. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20:2423–2435.
   PubMed Web of Science ®Google Scholar
• Harper, J. W. 2002. A phosphorylation-driven ubiquitination switch for cell-cycle control. Trends Cell Biol. 12:104–107.
   PubMedGoogle Scholar
• Heaney, A. P., R. Singson, C. J. McCabe, V. Nelson, M. Nakashima, and S. Melmed. 2000. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355:716–719.
   PubMed Web of Science ®Google Scholar
• Hornig, N. C., P. P. Knowles, N. Q. McDonald, and F. Uhlmann. 2002. The dual mechanism of separase regulation by securin. Curr. Biol. 12:973–982.
   PubMed Web of Science ®Google Scholar
• Jackson, P. K., A. G. Eldridge, E. Freed, L. Furstenthal, J. Y. Hsu, B. K. Kaiser, and J. D. Reimann. 2000. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 10:429–439.
   PubMed Web of Science ®Google Scholar
• Jallepalli, P. V., I. C. Waizenegger, F. Bunz, S. Langer, M. R. Speicher, J. M. Peters, K. W. Kinzler, B. Vogelstein, and C. Lengauer. 2001. Securin is required for chromosomal stability in human cells. Cell 105:445–457.
   PubMedGoogle Scholar
• Jin, D. Y., F. Spencer, and K. T. Jeang. 1998. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81–91.
   PubMed Web of Science ®Google Scholar
• Kakar, S. S., and L. Jennes. 1999. Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenet. Cell Genet. 84:211–216.
   PubMedGoogle Scholar
• Koepp, D. M., J. W. Harper, and S. J. Elledge. 1999. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97:431–434.
   PubMed Web of Science ®Google Scholar
• Leismann, O., A. Herzig, S. Heidmann, and C. F. Lehner. 2000. Degradation of Drosophila PIM regulates sister chromatid separation during mitosis. Genes Dev. 14:2192–2205.
   PubMedGoogle Scholar
• Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643–649.
   PubMed Web of Science ®Google Scholar
• Li, X., and D. M. Virshup. 2002. Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur. J. Biochem. 269:546–552.
   PubMedGoogle Scholar
• Losman, J. A., X. P. Chen, B. Q. Vuong, S. Fay, and P. B. Rothman. 2003. Protein phosphatase 2A regulates the stability of Pim protein kinases. J. Biol. Chem. 278:4800–4805.
   PubMed Web of Science ®Google Scholar
• Nasmyth, K. 2002. Segregating sister genomes: the molecular biology of chromosome separation. Science 297:559–565.
   PubMed Web of Science ®Google Scholar
• Patton, E. E., A. R. Willems, and M. Tyers. 1998. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 14:236–243.
   PubMed Web of Science ®Google Scholar
• Pei, L., and S. Melmed. 1997. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 11:433–441.
   PubMed Web of Science ®Google Scholar
• Peters, J. M. 2002. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9:931–943.
   PubMed Web of Science ®Google Scholar
• Peters, J. M. 1998. SCF and APC: the Yin and Yang of cell cycle regulated proteolysis. Curr. Opin. Cell Biol. 10:759–768.
   PubMedGoogle Scholar
• Pfleger, C. M., and M. W. Kirschner. 2000. The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1. Genes Dev. 14:655–665.
   PubMed Web of Science ®Google Scholar
• Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59–70.
   PubMed Web of Science ®Google Scholar
• Ramos-Morales, F., A. Dominguez, F. Romero, R. Luna, M. C. Multon, J. A. Pintor-Toro, and M. Tortolero. 2000. Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product. Oncogene 19:403–409.
   PubMedGoogle Scholar
• Romero, F., A. Germani, E. Puvion, J. Camonis, N. Varin-Blank, S. Gisselbrecht, and S. Fischer. 1998. Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner. J. Biol. Chem. 273:5923–5931.
   PubMedGoogle Scholar
• Romero, F., A. M. Gil-Bernabé, C. Sáez, M. A. Japón, J. A. Pintor-Toro, and M. Tortolero. 2004. Securin is a target of the UV response pathway in mammalian cells. Mol. Cell. Biol. 24:2720–2733.
   PubMedGoogle Scholar
• Romero, F., M. C. Multon, F. Ramos-Morales, A. Dominguez, J. A. Bernal, J. A. Pintor-Toro, and M. Tortolero. 2001. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res. 29:1300–1307.
   PubMed Web of Science ®Google Scholar
• Saez, C., M. A. Japon, F. Ramos-Morales, F. Romero, D. I. Segura, M. Tortolero, and J. A. Pintor-Toro. 1999. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18:5473–5476.
   PubMedGoogle Scholar
• Saez, C., T. Pereda, J. J. Borrero, A. Espina, F. Romero, M. Tortolero, J. A. Pintor-Toro, D. I. Segura, and M. A. Japon. 2002. Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene 21:8173–8177.
   PubMed Web of Science ®Google Scholar
• Sherman, F., G. R. Fink, and J. B. Hicks. 1986. Methods in yeast genetics. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Stemmann, O., H. Zou, S. A. Gerber, S. P. Gygi, and M. W. Kirschner. 2001. Dual inhibition of sister chromatid separation at metaphase. Cell 107:715–726.
   PubMed Web of Science ®Google Scholar
• Stratmann, R., and C. F. Lehner. 1996. Separation of sister chromatids in mitosis requires the Drosophila pimples product, a protein degraded after the metaphase/anaphase transition. Cell 84:25–35.
   PubMedGoogle Scholar
• Tan, P., S. Y. Fuchs, A. Chen, K. Wu, C. Gomez, Z. Ronai, and Z. Q. Pan. 1999. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha. Mol. Cell 3:527–533.
   PubMedGoogle Scholar
• Uhlmann, F., D. Wernic, M. A. Poupart, E. V. Koonin, and K. Nasmyth. 2000. Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell 103:375–386.
   PubMed Web of Science ®Google Scholar
• Wang, Z., R. Yu, and S. Melmed. 2001. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 15:1870–1879.
   PubMed Web of Science ®Google Scholar
• Winston, J. T., D. M. Koepp, C. Zhu, S. J. Elledge, and J. W. Harper. 1999. A family of mammalian F-box proteins. Curr. Biol. 9:1180–1182.
   PubMed Web of Science ®Google Scholar
• Wu, K., S. Y. Fuchs, A. Chen, P. Tan, C. Gomez, Z. Ronai, and Z.-Q. Pan. 2000. The SCFHOS/β-TRCP-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation. Mol. Cell. Biol. 20:1382–1393.
   PubMedGoogle Scholar
• Yamamoto, A., V. Guacci, and D. Koshland. 1996. Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae. J. Cell Biol. 133:85–97.
   PubMed Web of Science ®Google Scholar
• Yeh, E., M. Cunningham, H. Arnold, D. Chasse, T. Monteith, G. Ivaldi, W. C. Hahn, P. T. Stukenberg, S. Shenolikar, T. Uchida, C. M. Counter, J. R. Nevins, A. R. Means, and R. Sears. 2004. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat. Cell Biol. 6:308–318.
   PubMed Web of Science ®Google Scholar
• Zhang, X., G. A. Horwitz, T. R. Prezant, A. Valentini, M. Nakashima, M. D. Bronstein, and S. Melmed. 1999. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 13:156–166.
   PubMedGoogle Scholar
• Zou, H., T. J. McGarry, T. Bernal, and M. W. Kirschner. 1999. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 285:418–422.
   PubMed Web of Science ®Google Scholar
• Zur, A., and M. Brandeis. 2001. Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis. EMBO J. 20:792–801.
   PubMed Web of Science ®Google Scholar